Neurocrine Biosciences
NBIX
#1296
Rank
โ‚น1.653 T
Marketcap
โ‚น16,339
Share price
3.12%
Change (1 day)
22.78%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

EPS for Neurocrine Biosciences (NBIX)

EPS in 2023 (TTM): โ‚น162.35

According to Neurocrine Biosciences 's latest financial reports the company's current EPS (TTM) is โ‚น652.95. In 2022 the company made an earnings per share (EPS) of โ‚น150.82 an increase over its 2021 EPS that were of โ‚น89.00.

EPS history for Neurocrine Biosciences from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น162.357.64%
2022โ‚น150.8269.47%
2021โ‚น89.00-78.21%
2020โ‚น408.44990%
2019โ‚น37.4781.82%
2018โ‚น20.61-113.5%
2017-โ‚น152.700.62%
2016-โ‚น151.7657.28%
2015-โ‚น96.4925.61%
2014-โ‚น76.8218.84%
2013-โ‚น64.64-1085.71%
2012โ‚น6.56-89.71%
2011โ‚น63.70-500%
2010-โ‚น15.93-86.92%
2009-โ‚น121.78-43.48%
2008-โ‚น215.46-57.8%
2007-โ‚น510.5692.58%
2006-โ‚น265.11371.67%
2005-โ‚น56.21-52.76%
2004-โ‚น118.9736.56%
2003-โ‚น87.12-70%
2002-โ‚น290.41118.31%
2001-โ‚น133.038.4%
2000-โ‚น122.7248.86%
1999-โ‚น82.44-20%
1998-โ‚น103.05-479.31%
1997โ‚น27.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น66.51-89.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น548.18-16.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,894 343.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
-โ‚น18.74-102.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น190.17-129.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น485.26-25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-โ‚น707.28-208.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚น143.26-78.06%๐Ÿ‡ฌ๐Ÿ‡ง UK